Related Experiment Video
Updated: Jan 5, 2026

Pseudomonas aeruginosa Induced Lung Injury Model
Published on: October 29, 2014
Early Growth Response 1 Deficiency Protects the Host against Pseudomonas aeruginosa Lung Infection
Zheng Pang1, Renee Raudonis2, Craig McCormick2
1Department of Pathology, Dalhousie University, Halifax, Nova Scotia, Canada.
Abstract:
Pseudomonas aeruginosa is an opportunistic pathogen that is a common cause of nosocomial infections. The molecular mechanisms governing immune responses to P. aeruginosa infection remain incompletely defined. Early growth response 1 (Egr-1) is a zinc-finger transcription factor that controls inflammatory responses. Here, we characterized the role of Egr-1 in host defense against P. aeruginosa infection in a mouse model of acute bacterial pneumonia. Egr-1 expression was rapidly and transiently induced in response to P. aeruginosa infection. Egr-1-deficient mice displayed decreased mortality, reduced levels of proinflammatory cytokines (tumor necrosis factor [TNF], interleukin-1β [IL-1β], IL-6, IL-12, and IL-17), and enhanced bacterial clearance from the lung. Egr-1 deficiency caused diminished NF-κB activation in P. aeruginosa-infected macrophages independently of IκBα phosphorylation. A physical interaction between Egr-1 and NF-κB p65 was found in P. aeruginosa-infected macrophages, suggesting that Egr-1 could be required for assembly of heterodimeric transcription factors that direct synthesis of inflammatory mediators. Interestingly, Egr-1 deficiency had no impact on neutrophil recruitment in vivo due to its differential effects on chemokine production, which included diminished accumulation of KC (CXCL1), MIP2 (CXCL2), and IP-10 (CXCL10) and increased accumulation of LIX (CXCL5). Importantly, Egr-1-deficient macrophages and neutrophils displayed significant increases in nitric oxide production and bacterial killing ability that correlated with enhanced bacterial clearance in Egr-1-deficient mice. Together, these findings suggest that Egr-1 plays a detrimental role in host defense against P. aeruginosa acute lung infection by promoting systemic inflammation and negatively regulating the nitric oxide production that normally assists with bacterial clearance.
Insights
Early growth response 1 (Egr-1) surprisingly hinders host defense against Pseudomonas aeruginosa lung infections. Mice lacking Egr-1 showed reduced inflammation and better bacterial clearance, highlighting Egr-1
Area of Science:
- Immunology
- Microbiology
- Molecular Biology
Background:
- Pseudomonas aeruginosa is a major cause of hospital-acquired infections, with immune response mechanisms not fully understood.
- Early growth response 1 (Egr-1), a transcription factor, regulates inflammatory responses.
- The specific role of Egr-1 in host defense against P. aeruginosa pneumonia requires further elucidation.
Purpose of the Study:
- To investigate the function of Egr-1 in the host immune response during acute Pseudomonas aeruginosa lung infection.
- To determine the impact of Egr-1 deficiency on inflammation, bacterial clearance, and immune cell function.
Main Methods:
- Utilized a mouse model of acute bacterial pneumonia induced by P. aeruginosa.
- Assessed Egr-1 expression levels post-infection.
- Analyzed mortality rates, cytokine profiles, NF-κB activation, chemokine production, nitric oxide levels, and bacterial burden in Egr-1-deficient and wild-type mice.
Main Results:
- Egr-1 expression was transiently induced during P. aeruginosa infection.
- Egr-1-deficient mice exhibited reduced mortality, lower pro-inflammatory cytokine levels (TNF, IL-1β, IL-6, IL-12, IL-17), and enhanced bacterial clearance.
- Egr-1 deficiency led to decreased NF-κB activation, altered chemokine profiles, increased nitric oxide production, and improved bacterial killing by macrophages and neutrophils.
Conclusions:
- Egr-1 plays a detrimental role in host defense against P. aeruginosa acute lung infection.
- Egr-1 promotes systemic inflammation and impairs nitric oxide production, which is crucial for bacterial clearance.
- Targeting Egr-1 may represent a therapeutic strategy to enhance host defense against P. aeruginosa infections.
More Related Videos
Related Concept Videos
Stringent Response in E. coli
Pneumonia II: Pathophysiology
Oxygen Requirements and Growth Patterns

